Illinois Municipal Retirement Fund raised its position in Dolby Laboratories (NYSE:DLB – Free Report) by 33.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,933 shares of the electronics maker’s stock after purchasing an additional 10,871 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Dolby Laboratories were worth $2,579,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Teacher Retirement System of Texas raised its position in Dolby Laboratories by 19.1% during the fourth quarter. Teacher Retirement System of Texas now owns 115,772 shares of the electronics maker’s stock valued at $7,435,000 after acquiring an additional 18,579 shares in the last quarter. Paragon Capital Management Inc. acquired a new stake in Dolby Laboratories in the first quarter valued at approximately $1,306,000. JPMorgan Chase & Co. grew its position in Dolby Laboratories by 81.3% in the third quarter. JPMorgan Chase & Co. now owns 312,028 shares of the electronics maker’s stock worth $22,582,000 after acquiring an additional 139,900 shares in the last quarter. Norges Bank acquired a new position in shares of Dolby Laboratories during the 4th quarter worth $54,966,000. Finally, Versor Investments LP increased its stake in shares of Dolby Laboratories by 65.7% during the 4th quarter. Versor Investments LP now owns 22,548 shares of the electronics maker’s stock worth $1,448,000 after purchasing an additional 8,944 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $54.90, for a total value of $164,700.00. Following the sale, the senior vice president owned 80,603 shares of the company’s stock, valued at $4,425,104.70. This trade represents a 3.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP John D. Couling sold 7,667 shares of Dolby Laboratories stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total value of $407,884.40. Following the completion of the transaction, the senior vice president directly owned 118,727 shares in the company, valued at approximately $6,316,276.40. This represents a 6.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 47,458 shares of company stock worth $2,639,537 in the last 90 days. 37.93% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Read Our Latest Analysis on DLB
Dolby Laboratories Trading Down 0.2%
NYSE DLB opened at $48.97 on Monday. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $77.00. The company has a fifty day simple moving average of $52.91 and a 200 day simple moving average of $59.44. The company has a market cap of $4.63 billion, a P/E ratio of 19.36 and a beta of 0.81.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping the consensus estimate of $1.31 by $0.06. The firm had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Equities research analysts forecast that Dolby Laboratories will post 3.21 EPS for the current fiscal year.
Dolby Laboratories Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.9%. Dolby Laboratories’s dividend payout ratio is presently 56.92%.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
See Also
- Five stocks we like better than Dolby Laboratories
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
